What is Kivo, Inc?
Kivo, Inc. specializes in developing document and submission management software tailored for life science companies. Their flagship Kivo Document Management system functions as a Part 11 compliant document repository, incorporating ICH and regional templates. Complementing this, Kivo's Submission Orchestration tools streamline the assembly and management of regulatory submissions, facilitating efficient publishing and content tracking. The platform provides life science organizations with a unified view of their regulatory content, aiming to enhance compliance and operational efficiency in a highly regulated industry.
How much funding has Kivo, Inc raised?
Kivo, Inc has raised a total of $3M across 1 funding round:
Angel/Seed
$3M
Angel/Seed (2022): $3M with participation from Facet Life Sciences and Oregon Venture Fund
Key Investors in Kivo, Inc
Facet Life Sciences
Facet Life Sciences is an entity focused on guiding small life science companies through the complexities of drug, biologic, and medical device development, offering expert regulatory guidance for FDA approval and strategic support.
Oregon Venture Fund
Oregon Venture Fund is an investment firm committed to backing growth-stage companies and ambitious founding teams, with a mission to empower local entrepreneurs and scale businesses globally.
What's next for Kivo, Inc?
The recent major strategic investment signals a pivotal growth phase for Kivo, Inc. This capital infusion is expected to accelerate product development, expand market reach, and enhance the company's submission orchestration capabilities. With a focus on serving the complex needs of life science companies navigating stringent regulatory pathways, Kivo is poised to further solidify its position as a key technology provider in this specialized market. Future endeavors will likely involve deepening platform integration and broadening its suite of compliance-focused solutions.
See full Kivo, Inc company page
